Psychotic disorder: treatments, associated drugs and conditions
Summary:
We study 54,744 people who have Psychotic disorder. The information that eHealthMe analyzes includes:
- COVID vaccines that are associated with Psychotic disorder- Medications that treat Psychotic disorder and their effectiveness
- 2,053 drugs that are associated with Psychotic disorder
- 1,432 conditions that are associated with Psychotic disorder
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
Number of reports submitted per year:

COVID vaccines that are associated with Psychotic disorder:
- Psychotic disorder in Moderna COVID Vaccine
- Psychotic disorder in Pfizer BioNTech Covid Vaccine
- Psychotic disorder in Johnson and Johnson Covid Vaccine
Psychotic disorder treatments and how effective are they?
Common drugs associated with Psychotic disorder:
- Abilify: 2,059 reports
- Olanzapine: 1,731 reports
- Risperidone: 1,692 reports
- Clozapine: 1,680 reports
- Clozaril: 1,574 reports
- Risperdal: 1,551 reports
- Seroquel: 1,474 reports
- Zyprexa: 1,301 reports
- Lorazepam: 1,292 reports
- Loraz: 1,292 reports
All the drugs that are associated with Psychotic disorder:
- Psychotic disorder (2,053 drugs)
Common conditions associated with Psychotic disorder:
- Schizophrenia: 3,404 reports
- Depression: 2,338 reports
- Stress and anxiety: 1,068 reports
- Bipolar disorder: 979 reports
- Parkinson's disease: 978 reports
- Pain: 864 reports
All the conditions that are associated with Psychotic disorder:
- Psychotic disorder (1,432 conditions)
Browse all Psychotic disorder symptoms:
a b c d e f g h i j k l m n o p q r s t u v w x y zDo you take any medication?
- You can start a phase IV clinical trial to monitor drug safety and effectiveness.Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
Related publications that referenced our studies
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
How we gather our data?
Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference. Browse all conditions on eHealthMe.
Recent studies on eHealthMe:
- Rifampin and Hydrocodone Bitartrate And Acetaminophen drug interaction - 3 seconds ago
- Telmisartan and Rheumatoid Nodule - 4 seconds ago
- Glimepiride and Toothaches - 8 seconds ago
- Pegintron and Myasthenia Gravis Aggravated - 9 seconds ago
- Hydrochlorothiazide and Hyperreflexia - 14 seconds ago
- Stadol and Augmentin '125' drug interaction - 14 seconds ago
- Loperamide Hydrochloride and Proctofoam Hc drug interaction - 18 seconds ago
- Zofran and Bi-Polar - 29 seconds ago
- Zofran and Bipolar Disorder - 29 seconds ago
- Xolair and Swelling Face - 29 seconds ago